HAPPE Spine's INTEGRATE®-C System Transforms Lives of Over 1,000 Patients

HAPPE Spine: Achieving Milestone with INTEGRATE®-C System

HAPPE Spine, a pioneering company in the orthopedic device industry, recently announced a significant achievement: their INTEGRATE®-C Interbody Fusion System has been successfully implanted in over 1,000 patients. This milestone underscores the growing clinical adoption of their innovative biomaterial technology across 30 different surgeons at 40 facilities throughout the country.

Medical professionals express enthusiasm about the results facilitated by the INTEGRATE®-C system. Dr. George S. Naseef, MD, who serves as the President of the Advanced Spine Center and Interim Chairman of the Department of Orthopedic Surgery at Morristown Medical Center in New Jersey, praises the system for promoting earlier fusion and higher success rates compared to traditional 3D-printed metal alternatives, particularly in complex multilevel cases. He highlights that the post-operative imaging is not marred by metal artifacts, offering a clearer view of surgical outcomes. Additionally, he notes the system provides a more stable fit in comparison to PEEK devices previously utilized.

HAPPE Spine's recent success has been bolstered by a bridging funding round that surpassed expectations earlier this year, aimed at further clinical validation of the INTEGRATE®-C system and expanding manufacturing capabilities to meet the growing demand. In an exciting development, HAPPE also successfully completed the MedTech Innovator 2025 Accelerator Cohort, making the list of 65 selected companies from nearly 1,500 global applicants. This cohort is known for nurturing medical technology startups, boasting over 700 alumni who have collectively raised more than $10 billion in subsequent funding and have introduced over 500 products to the market.

At its core, HAPPE Spine believes in enhancing patient care through innovative orthopedic implants. Their approach centers around the proprietary Hydroxyapatite Porous Polyetheretherketone (HAPPE®) biomaterial platform, which mimics biological tissue through its porous structure and embedded hydroxyapatite. This property enables the HAPPE® material to actively participate in the healing process, fostering robust bone growth both within and around the implant, as demonstrated in various preclinical studies. However, it is important to note that the performance observed in laboratory or animal studies may not always equate to clinical results.

HAPPE Spine aims to revolutionize spinal health and has set its sights on serving even more patients and healthcare providers in the future. For more comprehensive information about their impactful innovations, visit their official site at happeortho.com.

In summary, the journey of HAPPE Spine reflects a commitment to improving clinical outcomes in spinal health through cutting-edge technology, evidenced by their growth and the trust exhibited by healthcare professionals who advocate for their systems. The numbers speak volumes: more than 1,000 patients have benefited from the INTEGRATE®-C system, and this is likely just the beginning of HAPPE Spine's impact in orthopedic advancements.